Literature DB >> 1311994

Up-regulation of tumour necrosis factor-alpha receptors on monocytes by desferrioxamine.

C Philippe1, B Fouqueray, J Perez, L Baud.   

Abstract

The effect of endogenously generated reactive oxygen metabolites on the interaction of human blood monocytes with tumour necrosis factor-alpha (TNF-alpha) was investigated. Pre-exposure of unactivated human blood monocytes to dimethylthiourea, a scavenger of hydroxyl radical (OH.), or to desferrioxamine (DFX), an iron chelator preventing the synthesis of OH., enhanced the specific binding of 125I-TNF-alpha to its receptors. Scavengers of superoxide anion or hydrogen peroxide were without effect. DFX-induced up-regulation of 125I-TNF-alpha binding depended on the concentration of the drug (1-5 mM) and on the duration of the treatment (1-18 h). It was not due to a reduction of receptor occupancy by endogenously generated TNF-alpha. Scatchard analysis of binding data revealed that DFX caused an approximately two-fold increase in the number of type II TNF-alpha receptors, with no change in their affinity. This up-regulation, that did not require synthesis of new proteins, was associated with a decrease in the internalization rate of TNF-alpha receptors, the half-life of which was doubled. Conversely, these findings suggest that OH. generation by monocytes may have a physiological role in reducing the activity of membrane-associated TNF-alpha receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311994      PMCID: PMC1554334          DOI: 10.1111/j.1365-2249.1992.tb03026.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Induction of plasma inhibitors of interleukin 1 and TNF-alpha activity by endotoxin administration to normal humans.

Authors:  G A Spinas; D Bloesch; M T Kaufmann; U Keller; J M Dayer
Journal:  Am J Physiol       Date:  1990-11

2.  In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients.

Authors:  J Cadranel; C Philippe; J Perez; B Milleron; G Akoun; R Ardaillou; L Baud
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors.

Authors:  H P Hohmann; M Brockhaus; P A Baeuerle; R Remy; R Kolbeck; A P van Loon
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

4.  A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Authors:  T Kohno; M T Brewer; S L Baker; P E Schwartz; M W King; K K Hale; C H Squires; R C Thompson; J L Vannice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.

Authors:  M Lantz; U Gullberg; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release.

Authors:  D S Webb; Y Shimizu; G A Van Seventer; S Shaw; T L Gerrard
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

7.  Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide.

Authors:  A H Ding; E Sanchez; S Srimal; C F Nathan
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

8.  Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.

Authors:  H Engelmann; D Novick; D Wallach
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

9.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

Authors:  M Lotz; J H Vaughan; D A Carson
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

10.  Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.

Authors:  S K Burchett; W M Weaver; J A Westall; A Larsen; S Kronheim; C B Wilson
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

View more
  3 in total

1.  Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes.

Authors:  Alasdair J Scott; Kieran P O'Dea; David O'Callaghan; Lynn Williams; Justina O Dokpesi; Louise Tatton; Jonathan M Handy; Philip J Hogg; Masao Takata
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

2.  Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients.

Authors:  J Cadranel; C Philippe; B Philippe; B Milleron; B Fouqueray; C Mayaud; L Baud
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine.

Authors:  C Philippe; P Roux-Lombard; B Fouqueray; J Perez; J M Dayer; L Baud
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.